Works matching IS 01615505 AND DT 2025 AND VI 66 AND IP 8

Results: 31

Errata.

Published in:: 2025
Publication type:: Correction Notice

Michael G. Stabin, PhD, CHP, 1957–2025.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 8, p. 1318, doi. 10.2967/jnumed.125.270764

By:

Siegel, Jeffry A.;
Zanzonico, Pat B.

Publication type:

Article

2024 SNMMI Highlights Lecture: Neurosciences.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 8, p. 1176, doi. 10.2967/jnumed.125.270521

By:

Carson, Richard

Publication type:

Article

Translating Discovery into Impact: Owen Witte Talks with Caius Radu and Johannes Czernin About a Life Dedicated to Science and Discovery.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 8, p. 1157, doi. 10.2967/jnumed.125.270520

By:

Witte, Owen;
Radu, Caius;
Czernin, Johannes

Publication type:

Article

Embracing Flow: Exploring Panta Rhei in the Context of Nuclear Medicine.

Published in:

2025

By:

Taïeb, David;
Prior, John O.;
Dierckx, Rudi A.J.O.

Publication type:

Editorial

Quantitative Measurement of Tau Burden in a Dual-Time-Window Dynamic PET Imaging Protocol with [18F]MK6240.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 8, p. 1299, doi. 10.2967/jnumed.125.270165

By:

Xia, Ye;
Dhaynaut, Maeva;
Chemli, Yanis;
Lois, Cristina;
Hanseeuw, Bernard J.;
Thibault, Emma;
Groot, Colin;
Ossenkoppele, Rik;
Johnson, Keith;
El Fakhri, Georges;
Normandin, Marc D.;
Guehl, Nicolas J.

Publication type:

Article

Interspecies Variability in Biodistribution and PET Imaging Performance of [18F]Di-PyL: A Dimeric, PSMA-Targeted PET Agent for Prostate Cancer.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 8, p. 1271, doi. 10.2967/jnumed.125.270069

By:

Chen, Yimin;
Zhang, Xiaojun;
Wang, Xinlin;
Liu, Yachao;
Zhang, Jinming;
Cui, Mengchao

Publication type:

Article

Feasibility of Short-Term Redifferentiation in Patients with Radioactive Iodine–Refractory Metastatic Thyroid Cancer.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 8, p. 1192, doi. 10.2967/jnumed.125.270055

By:

von Hinten, Johannes;
Viering, Oliver;
Bundschuh, Ralph A.;
Cagliyan, Feyza;
Wengenmair, Hermann;
Pfob, Christian H.;
Nagarajah, James;
Lapa, Constantin;
Kircher, Malte

Publication type:

Article

Reply to "177Lu-PSMA Radiopharmaceutical Therapy or Cabazitaxel?".

Published in:

2025

By:

Wenzel, Mike;
Groener, Daniel;
Chun, Felix K. H.;
Mandel, Philipp

Publication type:

Letter

Reply to "176Lu Radiation in Long–Axial-Field-of-View PET Scanners: A Nonissue for Patient Safety".

Published in:

2025

By:

Mostafapour, Samaneh;
van Sluis, Joyce;
Lammertsma, Adriaan A.;
Tsoumpas, Charalampos

Publication type:

Letter

The Use of PSMA PET/CT Improves Overall Survival in Men with Biochemically Recurrent Prostate Cancer Treated with Salvage Radiotherapy: Real-World Data from an Entire Country.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 8, p. 1217, doi. 10.2967/jnumed.125.269996

By:

Mogensen, Anna W.;
Torp-Pedersen, Christian;
Nørgaard, Mette;
Petersen, Lars J.;
Moe, Mette;
Zacho, Helle D.

Publication type:

Article

Meeting Upcoming Clinical and Diagnostic Needs in Oncologic Imaging: A Structured Reporting System for Fibroblast-Activation-Protein–Targeted Imaging—FAP-RADS Version 1.0.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 8, p. 1245, doi. 10.2967/jnumed.125.269914

By:

Novruzov, Emil;
Sheikh, Gabriel T.;
Mamlins, Eduards;
Holzgreve, Adrien;
Mori, Yuriko;
Ledderose, Stephan;
Klauschen, Frederik;
Watabe, Tadashi;
Gorin, Michael A.;
Pomper, Martin G.;
Herrmann, Ken;
Rowe, Steven P.;
Werner, Rudolf A.;
Giesel, Frederik L.

Publication type:

Article

177Lu-PSMA Radiopharmaceutical Therapy or Cabazitaxel?

Published in:

2025

By:

Froehner, Michael;
Zöphel, Klaus

Publication type:

Letter

176Lu Radiation in Long–Axial-Field-of-View PET Scanners: A Nonissue for Patient Safety.

Published in:

2025

By:

Carter, Lukas M.;
Milman, Rebecca;
Ocampo Ramos, Juan Camilo;
Kesner, Adam L.

Publication type:

Letter

Biodistribution and Radiation Dosimetry for [68Ga]Ga-LNTH-1363S, a Probe Targeting Fibroblast Activation Protein α.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 8, p. 1284, doi. 10.2967/jnumed.125.269793

By:

Enke, Johanna S.;
Schuller, Bradley W.;
Glantschnig, Lisa;
Kircher, Malte;
Bundschuh, Ralph A.;
Dierks, Alexander;
Patt, Marianne;
Fenn, Eric J.;
Rinscheid, Andreas;
Pfob, Christian H.;
Amor Coarasa, Alejandro;
Babich, John W.;
Hesterman, Jacob Y.;
Lapa, Constantin

Publication type:

Article

Evaluation of 134Ce/134La-PSMA-617 for PET Imaging and Auger Electron Therapy of Prostate Cancer.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 8, p. 1252, doi. 10.2967/jnumed.125.269751

By:

Bobba, Kondapa Naidu;
Wadhwa, Anju;
Bidkar, Anil P.;
Raveendran, Athira;
Garcia, Luis;
Greenland, Nancy;
Wilson, David M.;
Seo, Youngho;
VanBrocklin, Henry F.;
Flavell, Robert R.

Publication type:

Article

Semiquantitative PET Parameters Refine Prognosis in CAR T–Treated Lymphoma After 1 and 3 Months: A Prospective Single-Center Study.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 8, p. 1183, doi. 10.2967/jnumed.125.269670

By:

Farolfi, Andrea;
Casadei, Beatrice;
Malizia, Claudio;
Ussia, Riccardo;
Rocchi, Veronica;
Paccagnella, Andrea;
Gentilini, Marianna;
Nanni, Cristina;
Argnani, Lisa;
Zinzani, Pier Luigi;
Fanti, Stefano

Publication type:

Article

Efficacy, Safety, Blood Kinetics, and 213Bi Distribution Studies of [225Ac]Ac-SibuDAB in Prostate Cancer Patients.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 8, p. 1239, doi. 10.2967/jnumed.125.269655

By:

Schmitl, Stefan;
Kretschmer-Chott, Elisabeth;
Patronas, Eva-Maria;
Kramer, Gero;
Ritt, Philipp;
Fuchs, Elisabeth;
Weisbrod, Maximilian;
Nics, Lukas;
Mitterhauser, Markus;
Hacker, Marcus

Publication type:

Article

A Prospective Provincial Registry of 18F-PSMA PET/CT for Recurrent Prostate Cancer: Results for 4,135 Men.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 8, p. 1223, doi. 10.2967/jnumed.125.269653

By:

Kohan, Andres;
Metser, Ur;
Luke, William;
Rashid, Mohammed;
Langer, Deanna L.;
MacCrostie, Pamela;
Green, Bo;
Mak, Victor;
Kulkarni, Girish S.;
Finelli, Antonio;
Shayegan, Bobby;
Pautler, Stephen E.;
Klotz, Laurence;
Hagerty, Marlon;
Lavallée, Luke T.;
Hildebrand, Catherine;
Bauman, Glenn

Publication type:

Article

Prognostic Value of Posttherapy SPECT/CT for Overall Survival in Patients Undergoing [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy: Results from 3 Clinical Trials.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 8, p. 1265, doi. 10.2967/jnumed.125.269640

By:

Kashyap, Raghava;
Buteau, James P.;
Bressel, Mathias;
Eifer, Michal;
Bollampally, Neeraja;
Jackson, Price;
McIntosh, Lachlan;
Sandhu, Shahneen;
Hofman, Michael S.

Publication type:

Article

Histologic Ex Vivo Validation of the [18F]SITATE Somatostatin Receptor PET Tracer.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 8, p. 1204, doi. 10.2967/jnumed.125.269619

By:

Trautwein, Nils F.;
Mattern, Sven;
Hinterleitner, Martina;
Reischl, Gerald;
Schirrmacher, Ralf;
Steger, Volker;
Nadalin, Silvio;
Nikolaou, Konstantin;
Schwenck, Johannes;
Singer, Stephan;
la Fougère, Christian

Publication type:

Article

Establishing In Vitro Dosimetric Models and Dose–Effect Relationships for 177Lu-DOTATATE in Neuroendocrine Tumors.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 8, p. 1291, doi. 10.2967/jnumed.125.269470

By:

Tamborino, Giulia;
Engbers, Pleun;
de Wolf, Tijmen H.;
Reuvers, Thom G.A.;
Verhagen, Rob;
Konijnenberg, Mark;
Nonnekens, Julie

Publication type:

Article

A Vision for Gastrin-Releasing Peptide Receptor Targeting for Imaging and Therapy: Perspective from Academia and Industry.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 8, p. 1160, doi. 10.2967/jnumed.124.269444

By:

Morgat, Clément;
Duan, Heying;
Dalm, Simone;
Hindié, Elif;
Günther, Thomas;
Krause, Bernd J.;
Kramer, Vasko;
Cavelier, Florine;
Stephens, Andrew W.;
Moran, Stephen;
Lamb, Laura;
Iagaru, Andrei

Publication type:

Article

Translational Potential of Fluorescent PARP1 Inhibitor as a Molecular Contrast Agent for Diagnosis of Basal Cell Carcinoma.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 8, p. 1197, doi. 10.2967/jnumed.124.269428

By:

Ricanati, Miriam;
Harris, Ucalene;
Neumann, Neil M.;
Farabi, Banu;
Kurtansky, Nicholas;
Rossi, Anthony;
Chen, Chih-Shan J.;
Pulitzer, Melissa P.;
Rajadhyaksha, Milind;
Dusza, Stephen;
Dhir, Ashish;
Jain, Manu

Publication type:

Article

Summary Report of the SNMMI AI Task Force Radiomics Challenge 2024.

Published in:

2025

By:

Boellaard, Ronald;
Rahmim, Arman;
Eertink, Jacoba J.;
Duehrsen, Ulrich;
Kurch, Lars;
Lugtenburg, Pieternella J.;
Wiegers, Sanne E.;
Zwezerijnen, Gerben J.C.;
Zijlstra, Josée M.;
Heymans, Martijn W.;
Buvat, Irène

Publication type:

Editorial

Extravasation Frequency of [177Lu]Lu-DOTATATE: Insights and Implications Derived from 1,314 Cycles of Treated Patients—A Single-Site Analysis.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 8, p. 1258, doi. 10.2967/jnumed.124.269411

By:

Kayal, Gunjan;
Augensen, Finn;
Bodei, Lisa;
Chu, Bae;
Marquis, Harry;
Carter, Lukas M.;
Humm, John;
Kesner, Adam L.

Publication type:

Article

Automated Total-Body Perfusion Imaging with 15O-Water PET Using Basis Functions and Organ-Specific Model Selection.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 8, p. 1307, doi. 10.2967/jnumed.124.269409

By:

Åhlström, Anna;
Lindström, Elin;
Maaniitty, Teemu;
Iida, Hidehiro;
Kärpijoki, Henri;
Sörensen, Jens;
Knuuti, Juhani;
Lubberink, Mark

Publication type:

Article

Noninvasive Characterization of Hepatic Lesions by Means of Glypican-3–Directed PET/CT.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 8, p. 1314, doi. 10.2967/jnumed.124.269290

By:

Scholtissek, Helen;
Reitsam, Nic G.;
Dierks, Alexander;
Kröncke, Thomas;
Märkl, Bruno;
Trepel, Martin;
Bundschuh, Ralph A.;
Lapa, Constantin

Publication type:

Article

Preirradiation of Spheroids with 225Ac-Trastuzumab Improves Penetration of 225Ac-Liposomes and MIRDcell Predictions of Responses to Drug Cocktails.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 8, p. 1278, doi. 10.2967/jnumed.124.269273

By:

Tallam, Hima;
Nair, Rajiv;
Sarkar, Aira;
Katugampola, Sumudu;
Sofou, Stavroula;
Howell, Roger W.

Publication type:

Article

Imaging Efficacy of [18F]CTT1057 PET/CT in Patients with Biochemically Recurrent Prostate Cancer: Results from GuidePath—A Phase 3, Prospective Multicenter Study.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 8, p. 1210, doi. 10.2967/jnumed.124.269266

By:

Fanti, Stefano;
Robles Barba, Javier Jesus;
Behr, Spencer;
Maurer, Tobias;
Paredes, Pilar;
Walz, Jochen;
Duch, Joan;
Perdigo, Marc Simo;
Mainta, Ismini Charis;
Bonnefoy, Pierre Benoit;
Coulanges, Medge;
Tang, Jun;
Seigne, Christelle;
Wilke, Celine;
Catafau, Ana M.;
Iagaru, Andrei;
Aggarwal, Rahul;
Taieb, David;
Gabriel, Sophie;
Paulina, Asseeva

Publication type:

Article

Imaging Efficacy of [18F]CTT1057 PET for the Detection of PSMA-Positive Tumors Using Histopathology as Standard of Truth: Results from the GuideView Phase 2/3 Prospective Multicenter Study.

Published in:

Journal of Nuclear Medicine, 2025, v. 66, n. 8, p. 1232, doi. 10.2967/jnumed.124.269007

By:

Iagaru, Andrei;
Suarez, Jose F.;
Behr, Spencer;
Aggarwal, Rahul;
Paredes, Pilar;
Buffi, Nicolo;
Penhoat, Thomas;
Ceci, Francesco;
Walz, Jochen;
Doumerc, Nicolas;
Coulanges, Medge;
Xu, Zhongying;
Seigne, Christelle;
Wilke, Celine;
Catafau, Ana M.;
Fanti, Stefano;
Maurer, Tobias

Publication type:

Article

Works matching IS 01615505 AND DT 2025 AND VI 66 AND IP 8

Errata.

Michael G. Stabin, PhD, CHP, 1957–2025.

2024 SNMMI Highlights Lecture: Neurosciences.

Translating Discovery into Impact: Owen Witte Talks with Caius Radu and Johannes Czernin About a Life Dedicated to Science and Discovery.

Embracing Flow: Exploring Panta Rhei in the Context of Nuclear Medicine.

Quantitative Measurement of Tau Burden in a Dual-Time-Window Dynamic PET Imaging Protocol with [<sup>18</sup>F]MK6240.

Interspecies Variability in Biodistribution and PET Imaging Performance of [<sup>18</sup>F]Di-PyL: A Dimeric, PSMA-Targeted PET Agent for Prostate Cancer.

Feasibility of Short-Term Redifferentiation in Patients with Radioactive Iodine–Refractory Metastatic Thyroid Cancer.

Reply to "<sup>177</sup>Lu-PSMA Radiopharmaceutical Therapy or Cabazitaxel?".

Reply to "<sup>176</sup>Lu Radiation in Long–Axial-Field-of-View PET Scanners: A Nonissue for Patient Safety".

The Use of PSMA PET/CT Improves Overall Survival in Men with Biochemically Recurrent Prostate Cancer Treated with Salvage Radiotherapy: Real-World Data from an Entire Country.

Meeting Upcoming Clinical and Diagnostic Needs in Oncologic Imaging: A Structured Reporting System for Fibroblast-Activation-Protein–Targeted Imaging—FAP-RADS Version 1.0.

<sup>177</sup>Lu-PSMA Radiopharmaceutical Therapy or Cabazitaxel?

<sup>176</sup>Lu Radiation in Long–Axial-Field-of-View PET Scanners: A Nonissue for Patient Safety.

Biodistribution and Radiation Dosimetry for [<sup>68</sup>Ga]Ga-LNTH-1363S, a Probe Targeting Fibroblast Activation Protein α.

Evaluation of <sup>134</sup>Ce/<sup>134</sup>La-PSMA-617 for PET Imaging and Auger Electron Therapy of Prostate Cancer.

Semiquantitative PET Parameters Refine Prognosis in CAR T–Treated Lymphoma After 1 and 3 Months: A Prospective Single-Center Study.

Efficacy, Safety, Blood Kinetics, and <sup>213</sup>Bi Distribution Studies of [<sup>225</sup>Ac]Ac-SibuDAB in Prostate Cancer Patients.

A Prospective Provincial Registry of <sup>18</sup>F-PSMA PET/CT for Recurrent Prostate Cancer: Results for 4,135 Men.

Prognostic Value of Posttherapy SPECT/CT for Overall Survival in Patients Undergoing [<sup>177</sup>Lu]Lu-PSMA-617 Radiopharmaceutical Therapy: Results from 3 Clinical Trials.

Histologic Ex Vivo Validation of the [<sup>18</sup>F]SITATE Somatostatin Receptor PET Tracer.

Establishing In Vitro Dosimetric Models and Dose–Effect Relationships for <sup>177</sup>Lu-DOTATATE in Neuroendocrine Tumors.

A Vision for Gastrin-Releasing Peptide Receptor Targeting for Imaging and Therapy: Perspective from Academia and Industry.

Translational Potential of Fluorescent PARP1 Inhibitor as a Molecular Contrast Agent for Diagnosis of Basal Cell Carcinoma.

Summary Report of the SNMMI AI Task Force Radiomics Challenge 2024.

Extravasation Frequency of [<sup>177</sup>Lu]Lu-DOTATATE: Insights and Implications Derived from 1,314 Cycles of Treated Patients—A Single-Site Analysis.

Automated Total-Body Perfusion Imaging with <sup>15</sup>O-Water PET Using Basis Functions and Organ-Specific Model Selection.

Noninvasive Characterization of Hepatic Lesions by Means of Glypican-3–Directed PET/CT.

Preirradiation of Spheroids with <sup>225</sup>Ac-Trastuzumab Improves Penetration of <sup>225</sup>Ac-Liposomes and MIRDcell Predictions of Responses to Drug Cocktails.

Imaging Efficacy of [<sup>18</sup>F]CTT1057 PET/CT in Patients with Biochemically Recurrent Prostate Cancer: Results from GuidePath—A Phase 3, Prospective Multicenter Study.

Imaging Efficacy of [<sup>18</sup>F]CTT1057 PET for the Detection of PSMA-Positive Tumors Using Histopathology as Standard of Truth: Results from the GuideView Phase 2/3 Prospective Multicenter Study.